Orexin-A at a glance
A fast read for beginners, with evidence strength, route context, safety depth, and community activity surfaced before the deeper sections.
Orexin-A (hypocretin-1) is a 33-amino acid neuropeptide produced exclusively by a small cluster of neurons in the lateral hypothalamus (LH). Together with its related peptide orexin-B (hypocretin-2), it exerts powerful wake-promoting effects through activation of two G-protein coupled receptors: OX1R (with selectivity for orexin-A) and OX2R (activated by both). Orexin signaling is essential for maintaining sustained wakefulness: loss of orexinergic neurons (as in narcolepsy type 1) leads to sudden uncontrollable sleep episodes and cataplexy.
Beyond sleep-wake regulation, orexin-A is a central integrator of arousal, appetite, energy expenditure, stress response, reward circuitry, and autonomic function. It promotes noradrenergic, serotonergic, dopaminergic, and histaminergic neurotransmission - explaining its broad effects on alertness, motivation, and cognitive performance. Orexin-A levels are low during sleep and peak during active wakefulness and in response to novel environments or stressors.
Research interest in intranasal orexin-A administration has grown following studies showing that intranasal delivery can bypass the BBB and directly engage hypothalamic and brainstem orexin receptors. A key NASA-funded study demonstrated that intranasal orexin-A significantly reversed cognitive and performance deficits caused by sleep deprivation in rhesus macaques, approaching the efficacy of modafinil but through a more physiological mechanism. This has generated substantial interest in its potential for shift workers, military personnel, and narcolepsy treatment.
No human clinical trials of intranasal orexin-A for wakefulness promotion have been published, though suvorexant and lemborexant (orexin receptor antagonists) are FDA approved for insomnia, confirming the orexin axis as a validated pharmacological target. Human intranasal studies are at early exploratory stage.
Key Benefits
Saves this peptide to your Watchlist and helps you find new research, news, and questions later.